Lysine

Lysine

SCHEMBL1484683

CCCC[C@H](N)C(=O)O.NCCCC[C@H](N)C(=O)O

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Lysine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.80
SLC1A2 P43004 2/20 0.56
SLC1A1 P43005 2/20 0.56
SLC1A3 P43003 1/20 0.56
GNAI3 P08754 1/20 0.56
GNAO1 P09471 1/20 0.56
GNAI1 P63096 1/20 0.56
DPP8 Q6V1X1 2/20 0.55
DPP9 Q86TI2 2/20 0.55
DPP7 Q9UHL4 2/20 0.55
GRIK1 P39086 2/20 0.55
GRIK2 Q13002 2/20 0.55
DDAH1 O94760 3/20 0.51
ARG2 P78540 4/20 0.50
ARG1 P05089 3/20 0.50
DPP4 P27487 1/20 0.49
NOS1 P29475 4/20 0.49
NOS2 P35228 3/20 0.49
NOS3 P29474 2/20 0.49
CYP1A2 P05177 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lysine SCHEMBL1484680 1.00 GSR (0.80) GSRSLC1A2SLC1A1SLC1A3GNAI3
Lysine SCHEMBL7909339 1.00 GSR (0.80) GSRSLC1A2SLC1A1SLC1A3GNAI3
Lysine SCHEMBL27204234 0.96 GSR (0.80) GSRSLC1A2SLC1A1SLC1A3GNAI3
Lysine SCHEMBL26634433 0.96 GSR (0.80) GSRSLC1A2SLC1A1SLC1A3GNAI3
Lysine SCHEMBL28088035 0.96 GSR (0.80) GSRSLC1A2SLC1A1SLC1A3GNAI3
Lysine SCHEMBL2098773 0.96 GSR (0.80) GSRSLC1A2SLC1A1SLC1A3GNAI3
Lysine SCHEMBL17364355 0.94 GSR (0.71) GSRSLC1A2SLC1A1SLC1A3GNAI3
Lysine SCHEMBL28078435 0.94 GSR (0.71) GSRSLC1A2SLC1A1SLC1A3GNAI3
Lysine SCHEMBL9404153 0.94 GSR (0.77) GSRSLC1A2SLC1A1SLC1A3GNAI3
Dodecylamine SCHEMBL9441764 0.94 GSR (0.77) GSRSLC1A2SLC1A1SLC1A3GNAI3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114364355-A Multi-dose ophthalmic formulations and methods of treatment 犹他大学研究基金会 2022-04-15 CN disclosed
CN-112105320-A Treating myopia progression 犹他大学研究基金会 2020-12-18 CN disclosed
CN-107372272-B Long-acting physical sign device of cuttlefish based on endoskeleton cuttlebone 浙江海洋大学 2020-10-13 CN disclosed
US-20110077198-A1 COMPOSITIONS AND METHODS FOR INHIBITING THE ACTIVATION OF DSRNA-DEPENDENT PROTEIN KINASE AND TUMOR GROWTH INHIBITION NESTEC S.A. (CH) 2011-03-31 US disclosed
EP-1301530-A2 MULTIPLE ANTIGENIC PEPTIDES IMMUNOGENIC AGAINST STREPTOCOCCUS PNEUMONIAE The Government of the United States of America, as represented by the Secretary, Department of Health & Human Services (US) 2003-04-16 EP disclosed
WO-2002004497-A2 MULTIPLE ANTIGENIC PEPTIDES IMMUNOGENIC AGAINST STREPTOCOCCUS PNEUMONIAE THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2002-01-17 WO disclosed
WO-1996003158-A1 USE OF LOW MOLECULAR WEIGHT AMINO ACIDS IN OPHTHALMIC COMPOSITIONS ALCON LABORATORIES, INC. (US) 1996-02-08 WO disclosed
EP-0288087-B1 Method for producing protein containing nonprotein amino acids WAKUNAGA SEIYAKU KK (JP) 1995-02-22 EP disclosed
US-4879223-A Method for producing protein containing nonprotein amino acids WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) 1989-11-07 US disclosed
EP-0288087-A2 Method for producing protein containing nonprotein amino acids WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) 1988-10-26 EP disclosed